Doctors were amazed when the experimental cancer drug “cured” every patient in the study.

The drug dostarlimab was used in a study at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, where it cured all 18 participants with some form of rectal cancer

Doctors have noticed a remarkable success rate when using the drug dostarlimab
Doctors have noticed a remarkable success rate when using the drug dostarlimab

An experimental cancer drug had a remarkable success rate, apparently curing virtually every patient during a clinical trial.

The drug dostarlimab was given to 18 people with a type of rectal cancer every three weeks for six months in a study at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York.

The drug seemed to get rid of rectal cancer with minimal side effects, although scientists say it’s too early to tell if patients are fully cured.

Participants were followed over a year of treatment where the cancer appears to have disappeared.

And the lack of side effects comes with grueling standard treatment with the option of surgery, chemotherapy and radiation, while those with gut and sexual dysfunction can be left behind.







The drug was used in patients with rectal cancer
(

Picture:

(Getty Images/iStockphoto)

After the new treatment, all patients found their cancer was gone on physical examination, endoscopy, or PET and MRI scans, the MSKCC researchers said.

“I believe this is the first time in cancer history,” said Dr. Luis Diaz, one of the lead authors of the study and an oncologist at MSKCC, reported New York Times.

“It’s really exciting. I think it’s a big step forward for patients.”

He added that he believes this is just the “tip of the iceberg”.

dr Hanna Sanoff of the University of North Carolina’s Lineberger Comprehensive Cancer Center was not involved in the study, but she is also excited about the results.







dr Luis Diaz (second from left) said the results were “historic”.
(

Picture:

Memorial Sloan Kettering Cancer Center)

“Absolutely. I mean, I’m incredibly optimistic (…) we’ve never seen anything work for 100% of people in cancer medicine,” she said NPR.org.

“This drug belongs to a class of drugs called immune checkpoint inhibitors. And these are immunotherapy drugs that don’t directly attack the cancer itself, but instead get a person’s immune system to essentially do the work.

“And these are drugs that have been around for a while for melanoma and other cancers, but weren’t really part of routine colorectal cancer treatment until recently.”

dr Sanoff says the next stage is to test the drug more extensively.

“I really want us to do a larger study using this drug in a much more diverse setting to understand what the actual, true response rate will be,” she said.

“It’s not going to be 100% in the end. I hope I bite my tongue in the future, but I can’t imagine it’s going to be 100%, so I think we can really do this all the time.”

Continue reading

Continue reading

https://www.mirror.co.uk/news/us-news/doctors-left-astonished-experimental-cancer-27164315 Doctors were amazed when the experimental cancer drug "cured" every patient in the study.

Fry Electronics Team

Fry Electronics.com is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@fry-electronics.com. The content will be deleted within 24 hours.

Related Articles

Back to top button